Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding
Authors:
- 1 March 2003
- journal article
- clinical trial
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 88 (2) , F113-F118
Abstract
Objective: To compare the pharmacokinetics and efficacy of oral versus intravenous mixed micellar vitamin K prophylaxis in infants with cholestatic liver disease, a known risk factor for vitamin K deficiency bleeding. Design: Prospective randomised controlled study. Setting: Paediatric Liver Unit. Patients: Forty four infants less than 6 months of age with conjugated hyperbilirubinaemia. Main outcome measures: Serum concentrations of vitamin K1 and undercarboxylated prothrombin (PIVKA-II; a sensitive functional indicator of vitamin K status) before and for up to four days after a single dose of mixed micellar K1 1 mg intravenously or 2 mg orally. Comparison of K1 levels 24 hours after oral K1 with those from 14 healthy newborns given the same dose. Results: At admission, 18 infants (41%) had elevated levels of serum PIVKA-II and eight (18%) had low K1 concentrations, indicative of subclinical vitamin K deficiency. Median serum K1 concentrations were similar in the oral and intravenous groups at baseline (0.92 v 1.15 ng/ml), rising to 139 ng/ml six hours after intravenous K1 but to only 1.4 ng/ml after oral administration. In the latter group, the low median value (0.95 ng/ml) and wide range (< 0.15–111 ng/ml) of serum K1 compared unfavourably with the much higher levels (median 77, range 11–263 ng/ml) observed in healthy infants given the same oral dose, and suggested impaired and erratic intestinal absorption in cholestatic infants. The severity of malabsorption was such that only 4/24 (17%) achieved an incremental rise in serum K1 > 10 ng/ml. Conclusions: The intestinal absorption of mixed micellar K1 is unreliable in infants with conjugated hyperbilirubinaemia. Given the strong association between cholestasis and late vitamin K deficiency bleeding, these data provide an explanation for the failure of some oral vitamin K1 prophylaxis regimens in infants with latent cholestasis.Keywords
This publication has 62 references indexed in Scilit:
- Six years' experience of prophylactic oral vitamin KArchives of Disease in Childhood - Fetal and Neonatal Edition, 2000
- Oral Versus Intramuscular PhytomenadioneDrug Safety, 1999
- Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin KEuropean Journal of Pediatrics, 1997
- Improving the Vitamin K Status of Breastfeeding Infants With Maternal Vitamin K SupplementsPediatrics, 1997
- Production of a New Monoclonal Antibody Specific to Human Des-Gamma-Carboxyprothrombin in the Presence of Calcium Ions. Application to the Development of a Sensitive ELISA-TestJournal of Immunoassay, 1995
- Late Haemorrhagic Disease in Sweden 1987–89Acta Paediatrica, 1991
- Vitamin K Deficiency in Breast-Fed Infants at One Month of AgeJournal of Pediatric Gastroenterology and Nutrition, 1986
- Vitamin K deficiency in the newborn infant: Prevalence and perinatal risk factorsThe Journal of Pediatrics, 1986
- Vitamin K in infancyThe Journal of Pediatrics, 1985
- Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular CarcinomaNew England Journal of Medicine, 1984